Literature DB >> 24745614

Cell size as a prognostic factor in oncocytic poorly differentiated carcinomas of the thyroid.

Sofia Asioli1, Alberto Righi2, Marco Volante3, Luigi Chiusa4, Ricardo V Lloyd5, Gianni Bussolati4.   

Abstract

Histological and cytological criteria in predicting clinical outcomes in patients with oncocytic poorly differentiated carcinoma (PDC) of the thyroid were investigated. In a set of 102 PDC patients, we performed a computer-assisted evaluation of cell size based on two different methods. Univariate analysis showed that cell size was a discriminant prognostic parameter in oncocytic PDC (30 cases) but not in the non-oncocytic carcinoma cases (72 cases). Patients with oncocytic PDC with small-medium cell size had a significantly increased risk of death (P = .029) and a decrease of disease-free survival (P = .014). This correlation was absent in cases of non-oncocytic PDC, where age and extensive vascular invasion were significant indicators of progression. The proposed morphological signature shows a robust discriminatory ability when tested on the oncocytic PDC group, and cell size assessment could thus be proposed as an inexpensive and readily evaluable parameter for predicting prognosis and planning therapy in this tumor type.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cell size; Oncocytic; Poorly differentiated carcinomas; Prognosis; Thyroid

Mesh:

Year:  2014        PMID: 24745614     DOI: 10.1016/j.humpath.2014.02.027

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  2 in total

1.  Cytological Evaluation of Thyroid Lesions by Nuclear Morphology and Nuclear Morphometry.

Authors:  R Yashaswini; T N Suresh; A Sagayaraj
Journal:  J Cytol       Date:  2017 Oct-Dec       Impact factor: 1.000

2.  EWSR1 rearrangement in papillary thyroid microcarcinoma is related to classic morphology and the presence of small-cell phenotype.

Authors:  Bozidar Kovacevic; Ana Caramelo; Vesna Skuletic; Snezana Cerovic; Catarina Eloy
Journal:  Bosn J Basic Med Sci       Date:  2022-02-01       Impact factor: 3.363

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.